You are here: Home » Current Affairs » Coronavirus » News
Business Standard

World Coronavirus Dispatch: All of Switzerland's ICU beds are full

UK govt under lens for £17 bn Covid deals, new cases in Russia top 22,000 a day, six-day lockdown in South Australia, and other pandemic-related news across the globe

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Yuvraj Malik 

Coronavirus, covid, tests
Pfizer said it will work with four states — Rhode Island, Texas, New Mexico, and Tennessee — to refine their plans for delivering and administering its Covid-19 vaccine

govt under lens for £17 bn Covid contracts: Britain’s public spending watchdog has criticised the government for a series of failures when it awarded more than £17bn of contracts to private companies to tackle the crisis, including a lack of transparency, errors and potential conflicts of interest. The National Audit Office said the Cabinet Office and the Department of Health and Social Care had failed to explain why some companies with government connections or poor due diligence records were chosen to provide crucial services during the pandemic, such as supplying personal protective equipment or consulting and policy advice.

Read more here

Let’s look at the global statistics:

Total Confirmed Cases: 55,578,685

Change Over Yesterday: 586,114

Total Deaths: 1,337,559

Total Recovered: 35,739,244

Nations hit with most cases: US (11,350,143), India (8,874,290), Brazil (5,911,758), France (2,087,183) and Russia (1,954,912)

Source: Johns Hopkins Coronavirus Research Center

to work with four states for vaccine distribution: Drug maker said it will work with four states — Rhode Island, Texas, New Mexico, and Tennessee — to refine their plans for delivering and administering its Covid-19 vaccine before the vaccine receives its expected authorization. The step reflects the complexity of distributing on a large scale a vaccine that requires ultracold storage. Read on...

All of Switzerland’s intensive care beds are full: has reached capacity in its intensive care wards, a national medical association said Tuesday. The group urged people who are especially vulnerable to the to consider writing a living will, specifying whether they would want to be put on life support. The country, with a population of 8.5 million, has seen new infections explode recently, with more than 83,500 reported since 3 November. Read more here

New cases in Russia exceed 22,000 a day: The country’s anti-crisis centre reported 22,410 cases of Covid-19 in the previous 24 hours, the Tass news agency reported. Russia’s cumulative case total stands at 1,971,013, it added. However, Tass said, the number of active cases fell for the first time since September 17, declining from 461,265 to 461,178 people receiving hospital treatment. Read more here

South Australia announces a six-day lockdown: South Australia announced a six-day lockdown to help contain a growing cluster of Covid-19 infections, imposing the nation’s strictest state-wide stay-at-home orders since the pandemic began. From midnight, only one person from each household will be allowed to leave home each day, and only for specific purposes, authorities said. Schools, universities, cafes and restaurants will close and mask-wearing will be mandatory. Read more here

Specials

Covid shots barrel toward finish line in 300-day science feat

Bringing a conventional vaccine from inception to market takes more than a decade on average, and less than one in five that enters human trials gets to the finish line. A Merck & Co mumps vaccine that was developed in 1967 has the record for speed: four years. There are still many questions to be answered, including how long protection from the vaccines will last and how they’ll hold up under the scrutiny of regulators. They have to be manufactured and distributed to billions of people, in some cases under extreme conditions. Read more here

US FDA authorizes the first at-home coronavirus test

The test, developed by California-based company Lucira Health, requires a prescription from a health care provider. People under the age of 14 also can’t perform the test on themselves. But with a relatively simple nasal swab, the test can return results in about half an hour, and is projected by the company to cost $50 or less, according to the product’s website. linicians can also run the test on their patients, including children under the age of 14, potentially delivering answers during a single visit to a care center or pharmacy, instead of routing a tough-to-collect sample through a lab. A handful of other tests have been cleared by the FDA for at-home collection of samples, which are then shipped to a lab for processing. But Lucira’s test is the first to remove the need for an intermediary. Read more here

Info-graphics

World’s busiest airline routes during Covid times

Asia is a standout, home to all 10 of the world’s busiest domestic routes this month, according to OAG Aviation Worldwide. South Korea has the busiest by far, between its capital Seoul and the island Jeju. See all here

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 18 2020. 14:06 IST
RECOMMENDED FOR YOU